Abstract Tetralogy of Fallot (ToF) is the most common type of cyanotic congenital heart
disease. Since the first surgical repair in 1954, treatment has continuously improved. The …

Background There is no systematic evidence review of the long-term results of surgical
pulmonary valve replacement (PVR) dedicated to adults with repaired tetralogy of Fallot …

Background: Risk factors for adverse clinical outcomes have been identified in patients with
repaired tetralogy of Fallot before pulmonary valve replacement (PVR). However, pre-PVR …

Abstract Background Stented bioprosthetic valves (BPVs) are commonly used for surgical
pulmonary valve (PV) replacement in postoperative congenital heart disease, but develop …

Background: The arterial switch operation (ASO) is the gold standard operative correction of
neonates with transposition of the great arteries and intact ventricular septum, with excellent …

Abstract Purpose Patients with repaired Tetralogy of Fallot (rTOF) will develop dilation of the
right ventricle (RV) from chronic pulmonary insufficiency and require pulmonary valve …

Background Transcatheter pulmonary valve replacement (TPVR) has emerged as an
alternative to surgery in patients with pulmonary valve dysfunction. Methods We searched …

Few topics in adult congenital heart disease have approached the level of scrutiny bestowed
on pulmonary valve replacement (PVR) strategies late after tetralogy of Fallot (TOF) repair …

Background Transcatheter pulmonary valve replacement (TPVR) is associated with a risk of
procedural serious adverse events (SAE) and exposure to ionizing radiation. Objectives The …

Background Repaired tetralogy of Fallot (RTOF) patients will develop right ventricular (RV)
dysfunction from chronic pulmonary regurgitation (PR). Cardiac magnetic resonance …